벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2)

벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2)
벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) 구조식 이미지
카스 번호:
144675-97-8
한글명:
벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2)
동의어(한글):
벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2)
상품명:
Pixantrone Dimaleate
동의어(영문):
Pixantrone maleate;CS-1295;Bbr 2778;Dimalate salt;BBR 2778 dimaleate;Pixatrone dimaleate;Pixantrone Dimaleate;Pixantrone dimaleate (BBR-2778);Pixantrone dimaleate, 10 mM in DMSO;Pixantrone-dimaleate, BBR2778 dimaleate
CBNumber:
CB41245169
분자식:
C21H23N5O6
포뮬러 무게:
441.44
MOL 파일:
144675-97-8.mol
MSDS 파일:
SDS

벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) 속성

녹는점
192°
저장 조건
under inert gas (nitrogen or Argon) at 2-8°C
용해도
DMSO:30.0(Max Conc. mg/mL);53.8(Max Conc. mM)
H2O:5.0(Max Conc. mg/mL);9.0(Max Conc. mM)
물리적 상태
결정성 고체
색상
Blue to dark blue
수용성
H2O: 2mg/mL, clear
InChIKey
GORZTPPEWDXGBU-BTJKTKAUSA-N
SMILES
C(/C(=O)O)=C/C(=O)O.N(C1=CC=C(NCCN)C2C(C3=CN=CC=C3C(=O)C1=2)=O)CCN
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
WGK 독일 WGK 3
스토리지 클래스 13 - Non Combustible Solids
Hazard Classifications Muta. 2
Repr. 2
그림문자(GHS): Health Hazard (GHS08)Skull and Crossbones (GHS06)
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H300 삼키면 치명적임 급성 독성 물질 - 경구 구분 1,2 위험 P264, P270, P301+P310, P321, P330,P405, P501
H310 피부와 접촉하면 치명적임 급성 독성 물질 - 경피 구분 1,2 위험 P262, P264, P270, P280, P302+P350,P310, P322, P361, P363, P405, P501
H330 흡입하면 치명적임 급성 독성 물질 흡입 구분 1, 2 위험 P260, P271, P284, P304+P340, P310,P320, P403+P233, P405, P501
H370 장기(또는, 영향을 받은 알려진 모든 장기를 명시)에 손상을 일으킴(노출되어도 특정 표적장기 독성을 일으키지 않는다는 결정적인 노출경로가 있다면 노출경로를 기재) 특정 표적장기 독성 - 1회 노출 구분 1 위험 P260, P264, P270, P307+P311, P321,P405, P501
예방조치문구:
P260 분진·흄·가스·미스트·증기·...·스프레이를 흡입하지 마시오.
P262 눈, 피부, 의복에 묻지 않도록 하시오.
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
P270 이 제품을 사용할 때에는 먹거나, 마시거나 흡연하지 마시오.
P271 옥외 또는 환기가 잘 되는 곳에서만 취급하시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P284 호흡 보호구를 착용하시오.
P301+P310 삼켰다면 즉시 의료기관(의사)의 진찰을 받으시오.
P302+P350 피부에 묻은 경우,비눗물로 부드럽게 씻기
P304+P340 흡입하면 신선한 공기가 있는 곳으로 옮기고 호흡하기 쉬운 자세로 안정을 취하시오.
P307+P311 노출된 경우,독성 물질 센터 또는 의사에게 전화하기
P310 즉시 의료기관(의사)의 진찰을 받으시오. 삼켰다면 즉시 의료기관(의사)의 도움을 받으시오.
P320 긴급히 (…) 처치를 하시오.
P321 (…) 처치를 하시오.
P322 특정 조치(라벨의 … 참조)
P330 입을 씻어내시오.
P361 즉시 오염된 의복을 모두 벗을 것
P363 다시 사용전 오염된 의류는 세척하시오.
P403+P233 용기는 환기가 잘 되는 곳에 단단히 밀폐하여 저장하시오.
P405 밀봉하여 저장하시오.
P501 ...에 내용물 / 용기를 폐기 하시오.
NFPA 704
0
4 0

벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) C화학적 특성, 용도, 생산

개요

Pixantrone dimaleate was approved by European Medicine Agency (EMA) on May 10, 2012. It was developed and marketed as Pixuvri® by Cell Therapeutics in EU. (CTI Life Sciences).
Pixantrone dimaleate is a DNA intercalating agent indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive Non-Hodgkin B-cell Lymphomas (NHL).
Pixuvri® is available as lyophilised powder for infusion, containing 29 mg of free Pixantrone. The recommended dose is 50 mg/m2 of pixantrone on days 1, 8 and 15 of each 28-day cycle for up to 6 cycles.

화학적 성질

Blue Solid

출처

Pixantrone dimaleate, also known as BBR 2778, was first synthesized by Professors Krapcho and Hacker at the University of Vermont. The University of Vermont and the Boehringer Mannheim Italia research center co-identified the in vitro tumor cell cytotoxicity.

용도

Pixantrone is an antineoplastic drug belonging to group of antitumor antibiotics. Pixantrone is an anlogue of Mitoxantrone (M373425) and is just as potent in the treatment of multiple sclerosis with f ewer toxic effects on cardiac tissue. Studies suggest that Pixantrone significantly reduces amyloid beta (A beta(1-42)) neurotoxicity, a mechanism implicated in Alzheimer's disease.

제조 방법

The manufacturing scale synthesis of pixantrone dimaleate relies on several process modifications from the original synthesis reported by Krapcho in 1994. This modified procedure has provided active pharmaceutical ingredient (API) in high purity (>99%) and is acceptable for use in pharmaceutical applications (Scheme 25). Beginning with pyridine 3,4-dicarboxylic acid (129), generation of the corresponding anhydride 130 proceeded in 76% yield upon treatment with refluxing Ac2O. Next, an AlCl3-promoted Friedel–Crafts reaction of 1,4-difluorobenzene (131) with 130 under reflux conditions provided a mixture of nicotinic acid isomers 132a/132b in 84% yield, which were carried directly to the next step. Cyclization with fuming H2SO4 yielded the desired difluorobenzo-isoquinoline-dione core 133, which was further functionalized with ethylenediamine (134) to provide the free base of pixantrone. Subjection of the pixantrone free base to aqueous acetic anhydride and maleic acid provided pixantrone dimaleate (XX) in 92% yield over 3 steps.
Synthesis of pixantrone dimaleate
Synthesis of pixantrone dimaleate

생물학적 활성

Pixantrone (BBR 2778) is an aza-anthracenedione with enhanced antitumor activity due to its DNA-intercalating and topoisomerase II-poisoning activity. Pixantrone shows no signs of acute or delayed cardiotoxicity seen with anthracyclines mitoxantrone and doxorubicin (DOX), while exhibiting comparable in vivo efficacy against solid tumors in mice. Tests conducted on human myocardial strips ex vivo shows that not only pixantrone does not form superoxide anion and hydrogen peroxide (O2 and H2O2) seen with DOX due to redox activation, pixantrone and its metabolites, especially N-dealkylated, show competitive inhibition against DOX reduction. While mitoxantrone does not form O2 and H2O2 on its own, it synergizes with DOX to form more O2 and H2O2, whose formation and subsequent production of the long-lived metabolite doxorubicinol contribute to DOX cardiotoxicity.

참고 문헌

[1] A. PAUL KRAPCHO. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations[J]. Journal of Medicinal Chemistry, 1994, 37 6: 828-837. DOI:10.1021/jm00032a018.
[2] 170. Krapcho, A. P.; Hacker, M. P.; Cavalletti, E.; Giuliani, F. C. US Patent 5587382 A,1996.
[3] Spinelli, S.; Didomenico, R. WO Patent 9526189 A1, 1995.
[4] Krapcho, P. A. EP Patent 503537 A1, 1992

벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) 준비 용품 및 원자재

원자재

준비 용품


벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) 공급 업체

글로벌( 147)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Shanghai Boyle Chemical Co., Ltd.
sales@boylechem.com China 2914 55
J & K SCIENTIFIC LTD. 18210857532 18210857532
jkinfo@jkchemical.com China 96815 76
Chembest Research Laboratories Limited 021-20908456
sales@BioChemBest.com China 5994 61
JinYan Chemicals(ShangHai) Co.,Ltd. 13817811078
sales@jingyan-chemical.com China 9963 60
LGM Pharma 1-(800)-881-8210
inquiries@lgmpharma.com United States 2110 70
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32273 50
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 9920 65
China Kouting Group Limited +86 (21) 5811-6473 5811-6475
sales@koutingchina.com China 494 60
Shanghai potentpharm CO.,Ltd 13524892556
sales-cn@potentpharm.com China 1011 55
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7544 61

벤즈(g)이소퀴놀린-5,10-디온,6,9-비스((2-아미노에틸)아미노)-,(2Z)-2-부텐디오에이트(1:2) 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved